Ecto-5′-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 9, 2007, Pages 1352-1359

  Braganhol, Elizandra ^a   Tamajusuku, Alessandra S K ^a   Bernardi, Andressa ^a   Wink, Márcia R ^b   Battastini, Ana M O ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Adenosine; Cell proliferation; Ecto 5 NT CD73; Glioma; Quercetin

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE PHOSPHATE; ECTO 5' NUCLEOTIDASE; NUCLEOSIDE; QUERCETIN; 5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-DIPHOSPHATE; DRUG DERIVATIVE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GLIOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PURINE METABOLISM; SIGNAL TRANSDUCTION; DRUG ANTAGONISM; METABOLISM; TUMOR CELL LINE;

5'-NUCLEOTIDASE; ADENINE NUCLEOTIDES; ADENOSINE DIPHOSPHATE; CELL LINE, TUMOR; CELL PROLIFERATION; GLIOMA; HUMANS; QUERCETIN; RNA, MESSENGER;

EID: 34547840321     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.06.003     Document Type: Article

References (41)

1. James G., and Butt A.M. P2Y and P2X purinoceptor mediated Ca2 signaling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 447 (2002) 247-260
2. Araque A., Parpura V., Sanzgiri R.P., and Haydon P.G. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 22 (1999) 208-215
3. Holland E.C. Gliomagenesis: genetic alterations and mouse models. Nature 2 (2001) 120-129
4. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
5. Rathbone M.P., Middlemiss P.J., Gysbers J.W., Andrew A., Herman M., Reed J.K., Ciccarelli R., Di Iorio P., and Caciagli F. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59 (1999) 663-690
6. Zimmermann H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev. Res. 52 (2001) 44-56
7. Lemmens R., Vanduffel L., Teuchy H., and Culic O. Regulation of proliferation of LLC-MK2 cells by nucleosides and nucleotides: the role of ecto-enzymes. J. Biochem. 316 (1996) 551-557
8. Neary J.T., Kang Y., Bu Y., Yu E., Akong K., and Peters C.M. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J. Neurosci. 19 (1999) 4211-4220
9. Morrone F.B., Horn A.P., Stella J., Spiller F., Sarkis J.J.F., Salbego C., Lenz G., and Battastini A.M.O. Increased resistance of glioma cell lines to extracellular ATP cytotoxicity. J. Neuro-oncol. 71 (2005) 135-140
10. Spychala J. Tumor promoting functions of adenosine. Pharmacol. Ther. 87 (2000) 161-173
11. Zimmermann H. 5′-Nucleotidase: molecular structure and functional aspects. Biochem. J. 285 (1992) 345-354
12. Ludwig H.C., Rausch S., Schallock K., and Markakis E. Expression of CD73 (ecto-5′-nucleotidase) in 165 glioblastomas by immunohistochemistry and electromicroscopic histochemistry. Anticancer Res. 19 (1999) 1747-1752
13. Fastbom L., Pazos A., and Palacios J.M. The distribution of adenosine A1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience 22 (1987) 813-826
14. Turnay J., Olmo N., Reence G., Von der Mark K., and Lizarbe M.A. 5′-Nucleotidase activity in cultured cell lines: effect of different assay conditions and correlation with cell proliferation. In Vitro Cell. Dev. Biol. 25 (1989) 1055-1061
15. Navaro J.M., Olmo N., Turnay J., López-Conejo M.T., and Lizarbe M.A. Ecto-5(-nucleotidase from a human colon adenocarcinoma cell line. Correlation between enzyme activity and levels in intact cells. Mol. Cell. Biochem. 187 (1998) 121-131
16. Vogel M., Kowalewski H.J., Zimmermann H., Janetzko A., Margolis R.U., and Wollny H.E. Association of the HNK-1 epitope with 5′-nucleotidase from Torpedo marmorata. Biochem. J. 278 (1991) 199-202
17. Ujházy P., Berleth E.S., Pietkiewicz J.M., Kitano H., Skaar J.R., Ehrke M.J., and Mihich E. Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistence. Int. J. Cancer 68 (1996) 493-500
18. López-Lázaro M. Flavonoids as anticancer agents: structure-activity relationship study. Curr. Med. Chem. 2 (2002) 691-714
19. Dunnick J.K., and Hailey J.R. Toxicity and carcinogenicity studies of quercetin, a natural component of foods, Fundam. Appl. Toxicol. 19 (1992) 423-431
20. Conseil G., Baubichon-Cortay H., Dayan G., Jault J.M., Barron D., and Di Pietro A. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP and steroid binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9831-9836
21. Kavutcu M., and Melzig M.F. In vitro effects of selected flavonoids on the 5′-nucleotidase activity. Pharmazie 54 (1999) 457-459
22. Williams R.J., Spencer J.P.E., and Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radical Biol. Med. 36 (2004) 838-849
23. Wink M.R., Lenz G., Braganhol E., Tamajusuku A.S.K., Schwartsmann G., Sarkis J.J.F., and Battastini A.M.O. Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Lett. 198 (2003) 211-218
24. Braganhol E., Zamin L.L., Canedo A.D., Horn F., Tamajusuku A.S.K., Wink M.R., Salbego C., and Battastini A.M.O. Anti-proliferative effect of quercetin in human U138MG glioma cell. Anti-cancer Drugs 17 (2006) 663-671
25. Frizzo M.E., Soares F.A., Dall'Onder L.P., Lara D.R., Swanson R.A., and Souza D.O. Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res. 972 (2003) 84-89
26. 2+-ATPase activity. Anal. Biochem. 157 (1996) 375-380
27. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 218-541
28. Schwiebert E.M., and Zsembery A. Extracellular ATP as a signaling molecule for epithelial cells. Biochem. Biophys. Acta 1615 (2003) 7-32
29. Insel P.A., Ostrom R.S., Zambon A.C., Hughes R.J., Balboa M.A., Shehnaz D., Gregorian C., Torres B., Firestein B.L., Xing M., and Post S.R. P2Y receptors of MDCK cells: epithelial cell regulation by extracellular nucleotides. Clin. Exp. Pharmacol. Physiol. 28 (2001) 351-354
30. Morrone F.B., Jacques-Silva M.C., Horn A.P., Bernardi A., Schwartsmann G., Rodnight R., and Lenz G. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell line. J. Neuro-oncol. 64 (2003) 211-218
31. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., and Willians M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46 (1994) 143-156
32. Wyatt D.A., Edmunds M.C., Rubio R., Berne R.M., Lasley R.D., and Mentzer R.M. Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A1-adenosine receptors. Am. J. Physiol. 257 (1989) H1952-H1957
33. Lelievre V., Muller J.M., and Falcon J. Adenosine modulates cell proliferation in human colonic adenocarcinoma. I Possible involvement of adenosine A1 receptor subtypes in HT29 cells. Eur. J. Pharmacol. 341 (1998) 289-297
34. Lelievre V., Muller J.M., and Falcon J. Adenosine modulates cell proliferation in human colonic carcinoma. II Differential behavior of HT29, DLD-1, Caco-2 and SW403 cell lines. Eur. J. Pharmacol. 341 (1998) 299-308
35. Wink M.R., Braganhol E., Tamajusuku A.S.K., Casali E.A., Karl J., Barreto-Chaves M.L., Sarkis J.J.F., and Battastini A.M.O. Extracellular adenine nucleotides metabolism in astrocyte cultures from different brain regions. Neurochem. Int. 43 (2003) 621-628
36. Danylova V.M., Andrukhova O.V., BabiichukS V.S., Andrukhov O., and Babiichuk E.B. Catalytic characteristics of 5′-nucleotidase in the structure of cell membrane rafts in smooth muscles. Ukr. Biokhim. Zh. 75 (2003) 71-76
37. Fujimura Y., Yamada K., and Tachibana H. A lipid raft-associated 67 kDa laminin receptor mediates suppressive effect of epigallocatechin-3-O-gallate on FcepsilonRI expression. Biochem. Biophys. Res. Commun. 336 (2005) 674-681
38. Ludwig H.C., Rauch S., Schllock K., and Markakis E. Expression of CD73 (ecto-5′-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry. Anticancer Res. 19 (1999) 1747-1752
39. Kang T.B., and Liang N.C. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem. Pharmacol. 54 (1997) 1013-1018
40. Hugo F., Mazurek S., Zander U., and Eigenbrodt E. In vitro effect of extracellular AMP on MCF-7 breast cancer cells: inhibition of glycolysis and cell proliferation. J. Cell. Physiol. 153 (1992) 539-549
41. Stefanovic V., Mandel P., and Rosenberg A. Ecto-5′-nucleotidase of intact cultured C6 rat glioma cells. JBC 251 (1976) 3900-3905